APA stil citiranja

Duletić-Načinović, A., Dekanić, A., Hadžisejdić, I., Kušen, I., Matušan Ilijaš, K., Grohovac, D., . . . Jonjić, N. (2012). JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms: JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms. Collegium antropologicum, p. 6.

Chicago stil citiranja

Duletić-Načinović, Antica, Andrea Dekanić, Ita Hadžisejdić, Ivona Kušen, Koviljka Matušan Ilijaš, Dragana Grohovac, Blaženka Grahovac, and Nives Jonjić. "JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms: JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms." 2012: 6.

MLA stil citiranja

Duletić-Načinović, Antica, et al. "JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms: JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms." 2012: 6.